- Home
- TPH vs APLS Comparison
TPH vs APLS Comparison
Compare TPH & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPH
- APLS
- Stock Information
- Founded
- TPH 2009
- APLS 2009
- Country
- TPH United States
- APLS United States
- Employees
- TPH N/A
- APLS N/A
- Industry
- TPH Homebuilding
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- TPH Consumer Discretionary
- APLS Health Care
- Exchange
- TPH Nasdaq
- APLS Nasdaq
- Market Cap
- TPH 4.0B
- APLS 4.4B
- IPO Year
- TPH N/A
- APLS 2017
- Fundamental
- Price
- TPH $38.44
- APLS $34.59
- Analyst Decision
- TPH Buy
- APLS Buy
- Analyst Count
- TPH 4
- APLS 19
- Target Price
- TPH $47.33
- APLS $49.89
- AVG Volume (30 Days)
- TPH 652.1K
- APLS 3.6M
- Earning Date
- TPH 10-24-2024
- APLS 11-05-2024
- Dividend Yield
- TPH N/A
- APLS N/A
- EPS Growth
- TPH 17.76
- APLS N/A
- EPS
- TPH 4.83
- APLS N/A
- Revenue
- TPH $4,498,697,000.00
- APLS $715,216,000.00
- Revenue This Year
- TPH $20.75
- APLS $95.53
- Revenue Next Year
- TPH N/A
- APLS $12.94
- P/E Ratio
- TPH $7.95
- APLS N/A
- Revenue Growth
- TPH 13.08
- APLS 162.10
- 52 Week Low
- TPH $33.24
- APLS $24.34
- 52 Week High
- TPH $47.78
- APLS $73.80
- Technical
- Relative Strength Index (RSI)
- TPH 27.08
- APLS 61.76
- Support Level
- TPH $38.90
- APLS $31.76
- Resistance Level
- TPH $42.22
- APLS $34.98
- Average True Range (ATR)
- TPH 0.91
- APLS 1.53
- MACD
- TPH -0.46
- APLS -0.04
- Stochastic Oscillator
- TPH 1.92
- APLS 76.77
About TPH Tri Pointe Homes Inc.
Tri Pointe Homes Inc is an American construction company that focuses on residential construction. The company designs and builds single-family homes and condominiums through its portfolio of six regional housing brands. Its largest regional brands include Maracay Homes, which operates in Arizona, and TRI Pointe and Pardee Homes, which operate in California, Nevada, and Colorado. From a geographic perspective, California is TRI Pointe's largest source of revenue, followed by Arizona and Nevada. The company also operates in Texas, Oregon, and Virginia. TRI Pointe completes approximately 4,000 homes annually with an average selling price around $500,000. TRI Pointe also is involved in the sale and development of land.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.